4116 明基醫歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 31.01% | 6.60% | 4.59% | 2.92% |
| 2025Q1 | 32.26% | 5.93% | 5.69% | 4.06% |
| 2024Q4 | 30.83% | 7.91% | 7.68% | 5.32% |
| 2024Q3 | 30.51% | 7.00% | 7.07% | 5.06% |
| 2024Q2 | 30.48% | 7.12% | 7.01% | 5.19% |
| 2024Q1 | 29.56% | 5.66% | 5.65% | 4.21% |
| 2023Q4 | 30.78% | 9.83% | 10.04% | 6.67% |
| 2023Q3 | 28.10% | 8.28% | 8.20% | 6.10% |
| 2023Q2 | 29.90% | 5.93% | 6.68% | 4.11% |
| 2023Q1 | 31.26% | 6.29% | 6.67% | 5.19% |
| 2022Q4 | 31.15% | 6.01% | 6.26% | 4.96% |
| 2022Q3 | 29.25% | 6.87% | 7.94% | 6.47% |
| 2022Q2 | 27.25% | 7.66% | 7.88% | 6.30% |
| 2022Q1 | 28.96% | 3.37% | 16.73% | 16.03% |
| 2021Q4 | 38.01% | 5.60% | 6.20% | 5.30% |
| 2021Q3 | 34.46% | 3.56% | 4.84% | 3.76% |
| 2021Q2 | 30.49% | 0.84% | 2.10% | 1.58% |
| 2021Q1 | 36.31% | 2.28% | 3.16% | 2.22% |
| 2020Q4 | 42.13% | 11.51% | 11.89% | 9.84% |
| 2020Q3 | 40.88% | 8.20% | 8.38% | 6.35% |
| 2020Q2 | 35.16% | 2.66% | 4.27% | 3.42% |